Parker Institute for Cancer ImmunotherapyOvjeren akaunt

@parkerici

Our mission is to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases

San Francisco, CA
parkerici.org
Vrijeme pridruživanja: veljača 2016.
631 fotografija ili videozapis Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @parkerici

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @parkerici

  1. Prikvačeni tweet
    3. velj

    Checkpoint inhibitor extends the lives of many cancer patients. Some however develop side effects like type 1 diabetes. We assembled 20 institutions to unpack why some patients get autoimmune conditions+how to prevent them.

    1 proslijeđeni tweet 13 korisnika označava da im se sviđa
    Poništi
  2. prije 18 sati

    3/ The world needs bold ideas and bold actions to cure cancer. Join us to create a cancer-free world. Donate today: ➡️ ⬅️

    2 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  3. proslijedio/la je Tweet
    4. velj

    Today is World Cancer Day. Even though we face divisive times, we cannot let cancer win, this generation can end cancer. The moment to act is now and there’s reason to be hopeful about the future. Read my latest at:

    29 proslijeđenih tweetova 52 korisnika označavaju da im se sviđa
    Poništi
  4. prije 23 sata

    2/ Interim results shared during showed a combo of anti-CD-40, anti-PD-1 & chemo shrank tumors in the majority of advanced metastatic patients. and Apexigen

    1 reply 1 proslijeđeni tweet 5 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  5. prije 23 sata

    1/ It’s . The theme “I Am and I Will” asks how we're creating a cancer-free world. PICI is a cancer research nonprofit & we're accelerating research to find cures, like with our Ph1 clinical trial for advanced metastatic .

    1 reply 3 proslijeđena tweeta 15 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  6. 31. sij

    Collaboration + Resources ➡️ Opportunity ➡️ Impact. Scientists and share an insider look at how PICI has impacted them personally, their lab (led by & Taha Merghoub) and the field.

    2 proslijeđena tweeta 10 korisnika označava da im se sviđa
    Poništi
  7. 30. sij

    2/ Carl June, PICI director and leading expert in delivering successful T-cell therapy, says it appears promising to transform how we treat solid tumors because “we need to cure cancer, not turn it into a chronic disease.”

    7 proslijeđenih tweetova 14 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  8. 30. sij

    1/ British scientists discovered a new T-cell receptor that can kill most human cancer types, distinguishing between healthy cells and cancerous ones, and eliminating only the latter.

    1 reply 13 proslijeđenih tweetova 20 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  9. 29. sij

    2/ “Every time we perform a CAR T-cell treatment that leads to remission or we see a scan without any disease, it's always breathtaking. It never gets old, and we work to achieve therapeutic success for all who come to us for help and trust us to care for them." Dr. Steve Forman

    6 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  10. 29. sij

    1/ Steve Forman of is an award-winning researcher and PICI collaborator who was a forerunner in stem cell research and now a pioneer in CAR-T where he’s seen early success w/ therapy for . Meet Dr. Forman:

    1 reply 4 proslijeđena tweeta 16 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  11. proslijedio/la je Tweet
    24. sij

    Today at the we had the honor to hear from Dr.Millie Elizabeth Hughes-Fulford, former NASA astronaut who flew aboard a NASA Space Shuttle! Incrible data about space station immunology. Great way to start a Friday!🚀

    2 proslijeđena tweeta 8 korisnika označava da im se sviđa
    Poništi
  12. 24. sij

    Engineered CAR-T cell therapy that’s seen success against and can result in an immune overreaction, CRS. These scientists found a possible approach to prevent this dangerous side effect.

    4 proslijeđena tweeta 11 korisnika označava da im se sviđa
    Poništi
  13. 23. sij

    Research led by PICI director Antoni Ribas of identifies a new target PAK4. Inhibiting PAK4 could increase T cell infiltration into tumors.

    1 proslijeđeni tweet 5 korisnika označava da im se sviđa
    Poništi
  14. 22. sij

    2/ Including PICI Dir of Informatics Lacey Kitch's talk on CANDEL, a brand new tool built by PICI’s informatics team, and how it transforms the way massive amounts of data is captured & analyzed at PICI. Learn how we accelerate the science,

    3 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  15. 22. sij

    1/ Catch PICI staff TODAY at covering major topics including new strategies for the tumor microenvironment, checkpoint blockade therapy and more throughout the day.

    1 reply 2 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi
  16. proslijedio/la je Tweet
    22. sij

    “The system of academic recognition has to change in order for people to get truly comfortable sharing their data.” 💯 chatting with co-worker Theresa LaVallee at

    2 proslijeđena tweeta 10 korisnika označava da im se sviđa
    Poništi
  17. 21. sij

    Congratulations to cell therapy pioneer Phil Greenberg on receiving ’s Luminary Award! 🎉 PICI’s VP of Translational Med & Reg Affairs Theresa LaVallee will interview and honor him with the award, kicking off .

    7 proslijeđenih tweetova 26 korisnika označava da im se sviđa
    Poništi
  18. proslijedio/la je Tweet
    17. sij

    ⚡️Check our article by Ribas, Grasso and Abril-Rodriguez showing how targeting PAK4-Wnt-CTNNB1 improves , and the fab linked N&Vs by Thomas Gajewski News&Views Original Article

    , , i još njih 2
    9 proslijeđenih tweetova 27 korisnika označava da im se sviđa
    Poništi
  19. 17. sij

    📣 PICI expert at next week: Dir. of Research Sam Bucktrout chairs a panel on new tumor microenvironment strategies w/ PICI’s Mike Angelo and Travis Hollman .

    1 reply 2 proslijeđena tweeta 7 korisnika označava da im se sviđa
    Poništi
  20. 16. sij

    2/ PICI scientists Marcel van den Brink , Avery Posey et al. will also explore various topics and strategies at including microbiome in cancer, CAR-T therapy and more.

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
    Poništi

@parkerici još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·